NIH-funded research Fellowship grant

Investigating how a small protein affects heart function and calcium regulation

Official title: Determining the regulatory role of microprotein ALN on SERCA2a and heart contractility

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10994781 · Data updated 2026-11-12

This study is looking at a tiny protein called ALN that helps control calcium levels in heart cells, which is really important for keeping your heart healthy, and it aims to find out how ALN works with a calcium pump to better understand heart problems and discover new ways to improve heart health.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 28, 2024
Project endAugust 27, 2026
Funding year2024
Award (this year)$41,915
NIH project number1F30HL172585-01A1
Project IDNIH-10994781 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals under 21 years old who are experiencing heart-related issues or conditions that affect calcium regulation in the heart.

Less likely to help

Patients over 21 years old or those without heart disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of a microprotein called ALN in regulating calcium levels in heart cells, which is crucial for proper heart function. The study examines how ALN interacts with a key calcium pump, SERCA2a, and how its activity can be influenced by phosphorylation. By using various experimental techniques, including cell cultures and cardiomyocyte studies, the research aims to uncover new insights into calcium dysregulation in heart disease. This could lead to potential therapeutic targets for improving heart health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for heart disease by restoring proper calcium regulation in heart cells.

How similar studies have gone: Other research has shown promising results in targeting calcium regulation in heart disease, suggesting that this approach may be viable.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Hassel, Keira — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Hassel, Keira

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.